Abstract: The present disclosure provides systems and methods for automatically generating telemedicine platforms for providers. A marketplace of healthcare services and associated pricing and other terms is made available to employers, individuals, and/or health insurance companies. Employers and/or health insurance companies can select a subset of options from the marketplace to create a customizable sub-marketplace of healthcare services to offer to their employees or insureds. Providers may modify their offerings in the marketplace to fit within guidelines established by the employers or health insurance companies to be automatically included in the sub-marketplace of healthcare services.

Abstract: A drug dosage form is provided in the form of a solid tablet which is greater than 50% by weight the local anesthetic agent. The local anesthetic agent may be selected from the group consisting of an aminoamide, an aminoester, and a combination thereof. The drug tablet may be in the form of a mini-tablet which is greater than 70 wt % drug, with the balance being excipient. For example, the anesthetic agent may include lidocaine, in a salt or base form, combined with binder and lubricant excipients. Implantable drug delivery devices including the tablets are also provided, e.g., one or more of the drug tablets may be contained in a biocompatible housing. The drug tablets may be substantially cylindrical with flat end faces, and the device may have from 10 to 100 drug tablets aligned in the housing with the flat end faces of adjacent tablets abutting one another.

Abstract: The present disclosure provides systems and methods for automatically generating telemedicine platforms for providers. A marketplace of healthcare services and associated pricing and other terms is made available to employers, individuals, and/or health insurance companies. Employers and/or health insurance companies can select a subset of options from the marketplace to create a customizable sub-marketplace of healthcare services to offer to their employees or insureds. Providers may modify their offerings in the marketplace to fit within guidelines established by the employers or health insurance companies to be automatically included in the sub-marketplace of healthcare services.

Abstract: A digital health platform enables the creation of a curated selection of products available for recommendation by healthcare providers and/or purchase by patients. The digital health platform may further facilitate electronic medical record management, physician-customizable online portals, patient services, health-related online marketplaces, secure messaging services, vaccine management, on-demand translations, real-time sales support, and the like. The selection of a product for recommendation or purchase may be linked to the scheduling of a telemedicine consultation related to the selected product. A healthcare practitioner may provide immediate click-to-buy links to various products and services to facilitate an improved user-experience and increase compensation available to healthcare providers.

Abstract: The present disclosure provides systems and methods for automatically generating telemedicine platforms for providers. A marketplace of healthcare services and associated pricing and other terms is made available to employers, individuals, and/or health insurance companies. Employers and/or health insurance companies can select a subset of options from the marketplace to create a customizable sub-marketplace of healthcare services to offer to their employees or insureds. Providers may modify their offerings in the marketplace to fit within guidelines established by the employers or health insurance companies to be automatically included in the sub-marketplace of healthcare services.

Abstract: Medical devices, substrates and biologic therapies for bone repair and guided tissue regeneration are disclosed. More particularly, bone graft substitutes and bone void fillers which comprise a porous collagen matrix and calcium deficient hydroxyapatite ceramic granules for delivery of osteoinductive or other therapeutic agents are disclosed.

Abstract: The present disclosure provides systems and methods for automatically generating telemedicine platforms for providers. A marketplace of healthcare services and associated pricing and other terms is made available to employers, individuals, and/or health insurance companies. Employers and/or health insurance companies can select a subset of options from the marketplace to create a customizable sub-marketplace of healthcare services to offer to their employees or insureds. Providers may modify their offerings in the marketplace to fit within guidelines established by the employers or health insurance companies to be automatically included in the sub-marketplace of healthcare services.

Abstract: The present disclosure provides systems, methods, and workflows related to the validation and sharing of health credentials, including vaccination statuses. A single QR code is generated to provide trusted and third-party verification of vaccination and test status of a user, even when the vaccination and testing were performed by different entities.

Abstract: The present disclosure provides systems and methods for automatically generating telemedicine platforms for providers. A marketplace of healthcare services and associated pricing and other terms is made available to employers, individuals, and/or health insurance companies. Employers and/or health insurance companies can select a subset of options from the marketplace to create a customizable sub-marketplace of healthcare services to offer to their employees or insureds. Providers may modify their offerings in the marketplace to fit within guidelines established by the employers or health insurance companies to be automatically included in the sub-marketplace of healthcare services.

Abstract: The present disclosure is directed to dermatological formulations and their use for treating a variety of dermatological diseases and disorders, and for repairing and restoring a disrupted epidermal barrier, inhibiting inflammation, restoring a proper environment for maintaining a balanced symbiotic microbiome, and inhibiting the growth of pathogenic microorganisms in the epidermis—the outer layer of mammalian skin.

Abstract: The present disclosure is directed to dermatological formulations and their use for treating a variety of dermatological diseases and disorders, and for repairing and restoring a disrupted epidermal barrier, inhibiting inflammation, restoring a proper environment for maintaining a balanced symbiotic microbiome, and inhibiting the growth of pathogenic microorganisms in the epidermis—the outer layer of mammalian skin.

Abstract: Healthcare practitioners may incorporate a microsite into their existing website to begin offering telemedicine visits. From a patient's perspective, the microsite appears to be newly added functionality to the healthcare practitioner's existing website. A microsite configurator can automatically deploy, replicate and custom brand the microsite for any healthcare provider and associated existing website, electronic medical records, or the like. The microsite allows existing websites to begin offering telemedicine visits in a custom and seamless manner.

Abstract: Systems and methods are described herein for offering, providing, and charging for on-demand per-encounter liability coverage for healthcare practitioners engaged in telemedicine consultations in connection with a telemedicine platform. The per-encounter liability coverage may be provided to supplement an existing insurance policy of the healthcare practitioner that is, for example, limited to cover only in-person consultations. The on-demand per-encounter liability coverage may be offered in connection with enrollment by the healthcare practitioner in a telemedicine platform that facilitates various types of telemedicine consultations.

Abstract: The present disclosure is directed to topical dermatological formulations, dermatological cleansing compositions, and bathwater conditioners designed to acidify the skin, and their use for restoring epidermal acidity, restoring a the epidermal barrier, inhibiting inflammation, establishing an environment appropriate for maintaining a balanced symbiotic microbiome, and inhibiting the growth of pathogenic microorganisms in the epidermis—the outer layer of mammalian skin.

Abstract: Medical devices, substrates and biologic therapies for bone repair and guided tissue regeneration are disclosed. More particularly, bone graft substitutes and bone void fillers which comprise a porous collagen matrix and calcium deficient hydroxyapatite ceramic granules for delivery of osteoinductive or other therapeutic agents are disclosed.

Abstract: The present disclosure provides systems and methods for automatically generating telemedicine platforms for providers. A marketplace of healthcare services and associated pricing and other terms is made available to employers, individuals, and/or health insurance companies. Employers and/or health insurance companies can select a subset of options from the marketplace to create a customizable sub-marketplace of healthcare services to offer to their employees or insureds. Providers may modify their offerings in the marketplace to fit within guidelines established by the employers or health insurance companies to be automatically included in the sub-marketplace of healthcare services.

Abstract: The present disclosure is directed to topical dermatological formulations, dermatological cleansing compositions, and bathwater conditioners designed to acidify the skin, and their use for restoring epidermal acidity, restoring a the epidermal barrier, inhibiting inflammation, establishing an environment appropriate for maintaining a balanced symbiotic microbiome, and inhibiting the growth of pathogenic microorganisms in the epidermis—the outer layer of mammalian skin.

Abstract: Magneto-Mechanical Resonator Sensor with Mass Distribution Channel Some aspects of the present disclosure feature a sensing device (e.g. for temperature, moisture or detection of substances) comprising a magnetic bias layer, a resonator, a spacer, and an environmental change receptor. The spacer is disposed between the magnetic bias layer and the resonator. At least one of the resonator surfaces has a predefined channel. The environmental change receptor is disposed proximate to the predefined channel. In response to a change in environment, the environmental change receptor distributes along a part of the channel.

Abstract: Some aspects of the present disclosure feature a sensing device comprising a magnetic bias layer, a resonator, a spacer, and a housing. The spacer includes an environmental change receptor. The thickness of the environmental change receptor rapidly increases in response to a change to an environment variable.